AKT1 and breast carcinoma: Furthermore, a previous study demonstrated the miR-182-5p regulation on CMTM7 in breast cancer, demonstrating that EVs-miR-182-5p promoted tumor progression by regulating the CMTM7/EGFR/AKT signaling axis [39].